Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells - a prospective randomized trial

Long-term menopausal hormone treatment (MHT) has been associated with an increased risk of breast cancer [1]. This knowledge has resulted in a dramatic decline in the use of MHT during the last fifteen years. Still there are many women who request MHT for the alleviation of postmenopausal symptoms. Several factors have been identified to influence the risk of breast cancer, including breast tissue density as shown either by mammography or histology [2].

Source: Maturitas - April 3, 2019 Category: Primary Care Authors: Angelica Lind én Hirschberg, Edneia Tani, Kerstin Brismar, Eva Lundström Source Type: research